Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BAO PHARMA logo — Acting on the Needs of Patients

BAO PHARMA

Acting on the Needs of Patients

Founded 2019 China Shanghai, China 6 employees Series C Total: $100.00M Biopharma, Biotechnology +1

General Information

Company Name BAO PHARMA
Founded Year 2019
Location China Shanghai, China
Employees 6
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with BAO PHARMA. To contact BAO PHARMA, visit baopharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does BAO PHARMA compare?

A PDF of BAO PHARMA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting BAO PHARMA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About BAO PHARMA

**BAO PHARMA** is a biopharmaceutical company based in **China** that was founded in **2019**. The company's slogan, "Acting on the Needs of Patients," reflects its dedication to addressing patient needs. BaoPharma is involved in the discovery, development, and production of pharmaceutical recombinant enzymes, human protein hormones, and antibodies. Their product portfolio includes **human hyaluronidase PH20 (rhPH20)**, **human chymotrypsin**, **IgG cleaving enzyme**, **collagenase**, and **recombinant human protein hormones** such as **rhFSH, FSH-CTP, rhCG, and rhLH**. The company recently secured a noteworthy **$100.00M Series B investment** on **25 August 2022**. The investment was led by a group of prominent investors including **Oriental Fortune Capital, Haitong Innovation Capital Management, CenterLab, Jingtong Equity Investment, Sun Rock Capital**, and **Findowin Capital**. BaoPharma operates in the **biopharma**, **biotechnology**, and **pharmaceutical** industries and is equipped with **GMP-compliant manufacturing facilities**. Overall, BaoPharma's recent Series B investment demonstrates confidence from several reputable investors and emphasizes the potential and growth prospects of the company in the biopharmaceutical industry. With a focus on developing critical pharmaceutical enzymes and hormones, BaoPharma is well-positioned to make a significant impact in the global healthcare sector.

Business keywords: biopharmaceutical, GMP-compliant, recombinant enzymes, human protein hormones, antibodies, manufacturing facilities, pharmaceutical production, rhPH20, rhFSH, rhCG, rhLH, enzyme production, pharmaceutical research, Shanghai

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Undisclosed 4
Shanghai Healthcare Capital Shanghai STVC Group
Shanghai Healthcare Capital, Shanghai STVC Group +2
19 Jul 2024
Series B $100.00M 6
Oriental Fortune Capital Haitong Innovation Capital Management Sun Rock Capital
Oriental Fortune Capital, Haitong Innovation Capital Management +4
25 Aug 2022

BAO PHARMA Alternatives & Competitors

View All Alternatives
BAO PHARMA vs
Intellective Bio
Intellective Bio China

Your Trusted Development & Manufacturing Partner

Series C
5 employees
Biopharma, Biotechnology
BAO PHARMA vs
Biopolis S.L.
Biopolis S.L. Spain

Biopolis, S.L. is a leading microbial biotechnology company based in Valencia (Spain) offering Contr...

Private Equity
25 employees
Biotechnology, Health Care
BAO PHARMA vs
Wuhan Healthgen Biotechnology Corp.
Wuhan Healthgen Biotechnology Corp. China

Using rice as bioreactor to produce animal-free recombinant human albumin (OsrHSA)

19 employees
Biotechnology, Health Care
View all alternatives

FAQ About BAO PHARMA

Acting on the Needs of Patients
BAO PHARMA was founded in 2019.
BAO PHARMA is headquartered in Shanghai, China.
BAO PHARMA operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on biopharmaceutical, GMP-compliant, recombinant enzymes and human protein hormones.
BAO PHARMA has approximately 6 employees.
BAO PHARMA has completed 2 funding rounds, raising a total of $100.00M. The latest funding stage is Series C.
Top alternatives and competitors to BAO PHARMA include Intellective Bio, Biopolis S.L., Wuhan Healthgen Biotechnology Corp., Burrard Pharmaceuticals, Eastonpharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BAO PHARMA and Intellective Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BAO PHARMA, https://bouncewatch.com/company/bao-pharma, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes